Global Peptide Synthesis Market By Product Type(Equipment, Reagents & Consumables, Other Product Types) By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) By Application-Therapeutics(Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) By Diagnosis, By Research, By End-use (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization/Contract Research Organization, Academic & Research Institutes) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033
- Published date: Feb 2024
- Report ID: 18814
- Number of Pages: 393
- Format:
- keyboard_arrow_up
- 1. Peptide Synthesis Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Peptide Synthesis Market Overview
- 3.1. Peptide Synthesis Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Manufacturer Intensity Map
- 3.1. Peptide Synthesis Market Dynamics
- 4. Global Peptide Synthesis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Peptide Synthesis Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Under 75%
- 4.4. 75% to 85%
- 4.5. Above 85%
- 5. Global Peptide Synthesis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Peptide Synthesis Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Commercial
- 5.4. Academic Research
- 6. Global Peptide Synthesis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Peptide Synthesis Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Peptide Synthesis Market: Regional Trend Analysis
- 6.2. Europe
- 6.2.1. Europe Peptide Synthesis Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Rest of Europe
- 6.2.1. Europe Peptide Synthesis Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Peptide Synthesis Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia
- 6.3.1. Asia-Pacific Peptide Synthesis Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Peptide Synthesis Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Peptide Synthesis Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Peptide Synthesis Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Peptide Synthesis Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Peptide Synthesis Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Bachem
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. PolyPeptide
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. GL Biochem
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Xinbang
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Hybio
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. US VPeptides
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Thermofischer
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. ScinoPharm
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. Genscript
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 7.12. AnaSpec
- 7.12.1. Company Overview
- 7.12.2. Financial Highlights
- 7.12.3. Product Portfolio
- 7.12.4. SWOT Analysis
- 7.12.5. Key Strategies and Developments
- 7.13. New England Peptide
- 7.13.1. Company Overview
- 7.13.2. Financial Highlights
- 7.13.3. Product Portfolio
- 7.13.4. SWOT Analysis
- 7.13.5. Key Strategies and Developments
- 7.14. CPC Scientific
- 7.14.1. Company Overview
- 7.14.2. Financial Highlights
- 7.14.3. Product Portfolio
- 7.14.4. SWOT Analysis
- 7.14.5. Key Strategies and Developments
- 7.15. JPT
- 7.15.1. Company Overview
- 7.15.2. Financial Highlights
- 7.15.3. Product Portfolio
- 7.15.4. SWOT Analysis
- 7.15.5. Key Strategies and Developments
- 7.16.21st Century Bio
- 7.16.1. Company Overview
- 7.16.2. Financial Highlights
- 7.16.3. Product Portfolio
- 7.16.4. SWOT Analysis
- 7.16.5. Key Strategies and Developments
- 7.17. LifeTein
- 7.17.1. Company Overview
- 7.17.2. Financial Highlights
- 7.17.3. Product Portfolio
- 7.17.4. SWOT Analysis
- 7.17.5. Key Strategies and Developments
- 7.18. Proimmune
- 7.18.1. Company Overview
- 7.18.2. Financial Highlights
- 7.18.3. Product Portfolio
- 7.18.4. SWOT Analysis
- 7.18.5. Key Strategies and Developments
- 7.19. Biomatik
- 7.19.1. Company Overview
- 7.19.2. Financial Highlights
- 7.19.3. Product Portfolio
- 7.19.4. SWOT Analysis
- 7.19.5. Key Strategies and Developments
- 7.9. Thermofischer
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Peptide Synthesis Market Introduction
- Lonza Group AG Company Profile
- MP Biomedicals
- Novo Nordisk A/S.
- Genscript Biotech
- CEM Corporation
- Thermo Fisher Scientific Company Profile
- Creative Diagnostics
- Polypeptide Group
- Syngene, PuroSynth
- Merck KGaA Company Profile
- Bachem Holdings
- Biotage
- settingsSettings
Our Clients
- 18814
- Feb 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible| Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
